Literature DB >> 30591494

Prognostic Significance of Sarcopenia and Systemic Inflammatory Response in Patients With Esophageal Cancer.

Tomoyuki Matsunaga1, Hiroshi Miyata2, Keijiro Sugimura1, Masaaki Motoori3, Kei Asukai1, Yoshitomo Yanagimoto1, Yusuke Takahashi1, Akira Tomokuni1, Kazuyoshi Yamamoto1, Hirofumi Akita1, Junichi Nishimura1, Hiroshi Wada1, Hidenori Takahashi1, Masayoshi Yasui1, Takeshi Omori1, Masayuki Oue1, Masahiko Yano1.   

Abstract

BACKGROUND/AIM: The association between the presence of sarcopenia and systemic inflammatory response is unclear in patients with esophageal cancer. This study was performed to investigate the relationship between sarcopenia and systemic inflammatory response and clarify the effect of these factors on the prognosis in patients with esophageal cancer. PATIENTS AND METHODS: This study included 163 patients with esophageal cancer. The patients' body composition was assessed before esophagectomy using multifrequency bioelectrical impedance. The relationship between sarcopenia and inflammatory factors were investigated before surgery.
RESULTS: Sarcopenia was significantly associated with a high C-reactive protein-to-albumin (CRP/Alb) ratio (p=0.046). Patients with sarcopenia significantly associated with worse overall survival (OS) (p=0.025) and tended to show a worse recurrence-free survival (RFS) (p=0.065). A high CRP/Alb ratio was significantly associated with worse OS and RFS. Multivariate analysis revealed that among all inflammatory factors, only a high CRP/Alb ratio was an independent prognostic factor for RFS (p=0.022).
CONCLUSION: Sarcopenia is associated with systemic inflammatory response such as high CRP/Alb ratio, while the latter is an independent prognostic marker in patients with esophageal cancer. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  C-reactive protein-to-albumin ratio; Esophageal cancer; sarcopenia

Mesh:

Substances:

Year:  2019        PMID: 30591494     DOI: 10.21873/anticanres.13133

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

1.  Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.

Authors:  Gabriel F P Aleixo; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss; Claudio L Battaglini; Grant R Williams
Journal:  Oncologist       Date:  2019-11-12

Review 2.  Effects of enteral nutritional rich in n-3 polyunsaturated fatty acids on the nutritional status of gastrointestinal cancer patients: a systematic review and meta-analysis.

Authors:  Guang-Ying Wan; Li-Yuan Zheng; Hui-Qin Li; Hua Yuan; Hui Xue; Xiu-Ying Zhang
Journal:  Eur J Clin Nutr       Date:  2019-11-11       Impact factor: 4.016

Review 3.  Benefits of weight loss programs for breast cancer survivors: a systematic reviews and meta-analysis of randomized controlled trials.

Authors:  Shurui Wang; Ting Yang; Wanmin Qiang; Zihan Zhao; Aomei Shen; Fangyuan Zhang
Journal:  Support Care Cancer       Date:  2022-01-13       Impact factor: 3.359

4.  Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features.

Authors:  Claudio Corallo; Antonella Fioravanti; Sara Tenti; Gianluca Pecetti; Ranuccio Nuti; Nicola Giordano
Journal:  Rheumatol Int       Date:  2019-08-01       Impact factor: 2.631

5.  Safety analysis of early oral feeding after esophagectomy in patients complicated with diabetes.

Authors:  Zhisheng Jiang; Jing Luo; Mengqing Xu; Zhuangzhuang Cong; Saiguang Ji; Yifei Diao; Yang Xu; Yi Shen
Journal:  J Cardiothorac Surg       Date:  2021-03-26       Impact factor: 1.637

6.  The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels.

Authors:  Utku Oflazoglu; Sevinc Caglar; Huriye Erbak Yılmaz; Hülya Tas Önal; Umut Varol; Tarik Salman; Yasar Yildiz; Sinan Unal; Zeynep Gulsum Guc; Yuksel Kucukzeybek; Ahmet Alacacioglu; Mustafa Oktay Tarhan
Journal:  Eur Geriatr Med       Date:  2022-03-11       Impact factor: 3.269

7.  Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma.

Authors:  Ji-Feng Feng; Liang Wang; Xun Yang; You-Hua Jiang
Journal:  Cancer Manag Res       Date:  2019-07-31       Impact factor: 3.989

Review 8.  Bioelectrical Impedance Analysis for the Assessment of Sarcopenia in Patients with Cancer: A Systematic Review.

Authors:  Gabriel F P Aleixo; Shlomit S Shachar; Kirsten A Nyrop; Hyman B Muss; Claudio L Battaglini; Grant R Williams
Journal:  Oncologist       Date:  2019-11-12       Impact factor: 5.837

9.  Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer.

Authors:  Han Gyul Yoon; Dongryul Oh; Yong Chan Ahn; Jae Myoung Noh; Hongryull Pyo; Won Kyung Cho; Yun Mi Song; Minsu Park; Na Young Hwang; Jong-Mu Sun; Hong Kwan Kim; Jae Ill Zo; Young Mog Shim
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

10.  Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis.

Authors:  Zhenhua Liu; Hongtai Shi; Longyun Chen
Journal:  BMC Cancer       Date:  2019-11-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.